Physician profile
Arijit Dasgupta
NPI 1679529135
$6,280.01
in general payments reported to CMS, 2019-2025
33 companies · $1,671 in 2025
The $1,671 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,491 · 2020: $527 · 2022: $168 · 2023: $669 · 2024: $1,754 · 2025: $1,671.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,696 · Travel and Lodging: $1,399.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,695.51 |
| Travel and Lodging | $1,398.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,461.18 | 2019-2025 | Lifevest |
| Medtronic, INC. | $1,111.01 | 2023-2025 | Turbohawk, Hawkone, Euphora |
| Shockwave Medical, INC | $739.17 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Inari Medical, INC. | $435.49 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Novartis Pharmaceuticals Corporation | $408.06 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $295.51 | 2019-2024 | Andexxa |
| Amgen INC. | $252.72 | 2019-2024 | Repatha |
| Janssen Pharmaceuticals, INC | $231.29 | 2019-2020 | |
| Pfizer INC. | $155.45 | 2019-2020 | |
| Biotronik INC. | $130.42 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $124.77 | 2019-2025 | Camzyos, Eliquis |
| Medtronic Vascular, INC. | $114.13 | 2019-2020 | |
| Abiomed | $92.86 | 2025 | |
| Alnylam Pharmaceuticals INC. | $76.46 | 2019-2020 | |
| Vifor Pharma, INC. | $74.02 | 2019 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $71.00 | 2019 | |
| Abbott Laboratories | $70.71 | 2024-2025 | Diamondback Peripheral, Triclip, Supera |
| Sanofi-Aventis U.S. LLC | $55.63 | 2019 | |
| Irhythm Technologies, INC. | $44.57 | 2024 | Zio Monitor, Zio Xt Patch |
| Chiesi USA, INC. | $42.73 | 2019 | |
| Astellas Pharma US INC | $37.93 | 2019 | |
| Kestra Medical Technology Services, INC. | $34.76 | 2023-2025 | Assure Wcd |
| Glaxosmithkline, LLC. | $32.86 | 2023 | Shingrix, Arexvy |
| Portola Pharmaceuticals, LLC | $24.97 | 2019 | |
| Edwards Lifesciences Corporation | $23.05 | 2019 | |
| Alexion Pharmaceuticals, INC. | $21.37 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.69 | 2019 | |
| Philips North America LLC | $18.91 | 2024 | (P88) Igt Devices Fm |
| Livanova USA, INC. | $17.85 | 2019 | |
| Terumo Medical Corporation | $16.62 | 2025 | Glidewire, Angio-Seal |
| Ekos Corporation | $15.71 | 2019 | |
| Teleflex LLC | $14.57 | 2024 | Vascband |
| Cardiovascular Systems INC. | $14.54 | 2023 | Diamondback Peripheral |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arijit Dasgupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.